Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.

Pharmaceutical

Isosceles Pharmaceuticals

Brett J. Lanier

Robert B. Stein

Deborah Mosca

Mark A. Mannebach

Herbert Neuman

The Leadership Team at Isosceles Pharmaceuticals is responsible for shaping the strategic direction of the company and overseeing the development of innovative pain management therapies. This team collaborates to align the company's vision with operational objectives, ensuring the successful advancement of preclinical products while maintaining a strong commitment to safety and efficacy.

Leadership Team

About

Team members

Other teams at Isosceles Pharmaceuticals

Medical Advisors